Eithar Mohamed

Oct 10, 2024 | mdpi.com | Jochen Greiner |Eithar Mohamed |Daniel Fletcher |Patrick J Schuler

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Jun 20, 2024 | preprints.org | Jochen Greiner |Eithar Mohamed |Daniel Fletcher |Patrick J Schuler

PreprintReviewVersion 1This version is not peer-reviewedVersion 1: Received: 19 June 2024 / Approved: 20 June 2024 / Online: 20 June 2024 (08:30:47 CEST)Greiner, J.; Mohamed, E.; Fletcher, D. M.; Schuler, P. J.; Schrezenmeier, H.; Götz, M.; Guinn, B.-A. Immunotherapeutic Potential of Mutated NPM1 for the Treatment of AML. Preprints 2024, 2024061388. https://doi.org/10.20944/preprints202406.1388.v1Greiner, J.; Mohamed, E.; Fletcher, D. M.; Schuler, P. J.; Schrezenmeier, H.; Götz, M.; Guinn, B.-A.

May 31, 2024 | mdpi.com | Eithar Mohamed |Daniel Fletcher |Simon Hart |Barbara-ann Guinn

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.

Mar 28, 2024 | preprints.org | Daniel Fletcher |Simon Hart |Barbara-ann Guinn |Eithar Mohamed

Preprint Review Version 1 This version is not peer-reviewed Version 1 : Received: 27 March 2024 / Approved: 28 March 2024 / Online: 28 March 2024 (09:40:50 CET) Mohamed, E.; Fletcher, D.; Hart, S.; Guinn, B. Can Tumour Antigens Provide Diagnostic Biomarkers for Early-Stage Non-small Cell Lung Cancer?. Preprints 2024, 2024031720. https://doi.org/10.20944/preprints202403.1720.v1 Mohamed, E.; Fletcher, D.; Hart, S.; Guinn, B.